Mustang Bio stock surged over 180% on Monday after the FDA granted its brain cancer drug candidate an orphan drug designation.

U.S. District Judge John Bates vacated directives from the Department of Health and Human Services and the Office of Personnel and Management. However, he denied a broader request to prevent HHS from ...

Insightec, a global healthcare innovator dedicated to using focused ultrasound to transform patient care, announced today that the U.S. Food and ...

A new report from congressional researchers examines the state of law around a federal statute that prohibits gun possession ...

The firm’s rapid rise represents a burgeoning American health trend. Between 2019 and 2024 prescriptions for testosterone ...

Shares of Eton Pharmaceuticals rose sharply in premarket trading Tuesday after the pharmaceutical company said the Food and Drug Administration has accepted its application seeking approval of its ...

In a clinical trial, a few people who took small doses of CBD saw their liver enzyme levels rise to more than three times ...

Under the new leadership of Marty Makary, the FDA should focus more attention on the critical role of real-world clinical data — such as from health insurance databases — in the ongoing assessment of ...

A new drug originally developed to treat a different brain disease is now showing signs that it could help people with ...

Here are the key takeaways from the full Times Magazine story about the F.D.A.: The F.D.A.’s regulators have an enormous ...

Senators will have the Capitol to themselves when they return Tuesday for an abbreviated work week, with several items on the ...

It has been reported that homeopaths in Maharashtra, India, will soon be able to prescribe modern medicines after completing a six months course in pharmacology. The scope of what kinds of medicines ...